Neville Daniel

CEO Neville Daniel bought 17,000 shares of AFCG at $2.81; stock down 71.1% from 52-week high, company posted -$12.5M net income last quarter.

Neville Daniel purchased 17,000 shares at $2.81 on 2025-11-18, increasing his holdings from 209.6K to 226.6K shares. The purchase occurs in a sharply deteriorating context: the stock trades at -71.1% from its 52-week high of $9.76, down -16.8% over 30 days and -21.9% over 90 days. More concerning, AFCG reported $6.5M in quarterly revenue against a -$12.5M net loss, with annual revenue declining -28.9% year-over-year. Critically, Daniel's prior 5 trades at AFCG show a pattern of poor timing: across 3 completed 90-day periods, his buys resulted in 90d returns of -21.6%, -23.2%, and -28.1%—a 0% win rate. His cross-ticker track record reinforces this: 6 prior open-market buys averaged -21.3% over 90 days with a 0.00% win rate. This purchase follows the same trajectory his earlier AFCG buys established, occurring into a deteriorating stock and company fundamentals.

CEO Neville Daniel buys 12,388 shares of AFCG at $4.44; stock down 57.7% from 52-week high, CEO's prior buys at this ticker show 0 of 4 well-timed at 90 days.

Neville Daniel, CEO of Advanced Flower Capital Inc., purchased 12,388 shares at $4.44 on 2025-09-08, increasing his holdings by 6.3%. The transaction occurs while AFCG trades 57.7% below its 52-week high and amid significant operational headwinds: the company reported a net loss of $13,164,651.00 in the latest quarter, annual revenue has contracted 28.9%, and the stock has declined 19.3% over the past 90 days. Daniel's prior four measurable buys at AFCG all delivered negative 90-day returns (ranging from -12.4% to -28.1%), with zero instances of appreciation by the 90-day mark. While a cluster buy pattern with 2 other insiders in the past 14 days may suggest coordinated confidence, Daniel's cross-ticker track record shows 5 prior buys with an average 90-day return of -21.3% and a 0.00% win rate, indicating a consistent pattern of unfavorable timing across all open-market activity. The confluence of deteriorating fundamentals, continued share accumulation by an insider with a documented history of poorly-timed purchases, and the absence of a positive historical outcome at this ticker should prompt scrutiny of the underlying investment thesis.

CEO Neville Daniel bought 10,000 shares at $4.04; stock -60.6% from 52-week high, revenue -28.9% YoY, net loss $-13.2M.

CEO Neville Daniel purchased 10,000 shares at $4.04 on 2025-08-25, increasing his holdings to 197,261 shares. This occurs within a cluster pattern where 2 other insiders also bought within the past 14 days. However, the company's fundamentals are severely strained: the latest quarter showed revenue of $6,203,335.00 with a net loss of $-13,164,651.00, and annual revenue growth stands at -28.9%. The stock trades at $4.23, down 60.6% from its 52-week high of $10.75, after a 30-day decline of -7.2% and 90-day decline of -13.8%. Daniel's own prior trading pattern at this ticker is notably unfavorable: 4 previous buys, all showing negative 90-day returns (ranging from -12.4% to -28.1%), with a 0 of 4 win rate on a 90-day basis. This purchase represents continued accumulation despite persistent negative returns following his prior purchases and a deteriorating business fundamentals backdrop.

CEO Neville Daniel bought 5,000 shares of AFCG at $6.15 on 2025-03-28; stock down 55.6% from 52-week high, recent -34.7% decline in 30 days.

Neville Daniel, CEO of Advanced Flower Capital Inc., purchased 5,000 shares at $6.15 on 2025-03-28, bringing his holdings to 187,261 shares. This occurred amid significant recent stock deterioration: the stock trades 55.6% below its 52-week high of $12.54 and has declined 34.7% over the past 30 days. The company faces headwinds reflected in annual revenue declining 28.9% year-over-year, though most recent quarterly revenue stands at $8,882,316.00 and net income at $1,383,734.00. This marks the CEO's third purchase at AFCG within two weeks (prior buys on 2025-03-26 and 2025-03-17), suggesting consistent capital deployment during a marked downturn, though these recent transactions lack sufficient elapsed time for outcome assessment.

CEO Neville Daniel purchases 5,000 shares of AFCG at $6.20; stock down -27.6% in 90 days amid -28.9% revenue decline.

Neville Daniel, CEO of Advanced Flower Capital Inc., purchased 5,000 shares at $6.20 on 2025-03-26, expanding his holdings to 182,261 shares. This buy follows two prior purchases at AFCG within the preceding 9 days (2025-03-17 and 2025-03-14), as part of a cluster buy pattern involving 2 other insiders within the past 14 days. The transaction occurs against a backdrop of material headwinds: the stock is down -27.6% over 90 days and -52.0% from its 52-week high, while the company reported -28.9% annual revenue decline in its latest period. His track record across all open-market trades shows 2 prior buys, though outcomes on those prior AFCG trades are not yet measurable. The convergence of persistent insider buying amid significant equity decline and revenue contraction warrants investor attention to whether this pattern reflects conviction in mean reversion or inability to signal broader confidence through fundamental recovery.

CEO Neville Daniel purchased 46,599 shares ($300,575.48) in 2 transactions; +35.7% holdings increase amid -52.0% from 52-week high. Cluster buy pattern detected.

Neville Daniel, CEO of Advanced Flower Capital Inc., executed 2 separate purchases totaling 46,599 shares for $300,575.48 on March 14 and March 17, 2025, at prices of $6.52 and $6.32 respectively (blended $6.45). This increased his holdings by 35.7% from 130,662 to 177,261 shares. The timing is notable: the stock is trading at $6.30 current price, down 52.0% from its 52-week high of $13.11 and down 27.9% over the past 30 days, amid a challenging operating environment (annual revenue declined 28.9% year-over-year). A cluster buy pattern is present, with 2 other insiders also purchasing within the past 14 days, suggesting coordinated or aligned conviction at current price levels despite deteriorating fundamentals and significant recent price pressure.